Pravna regulacija umjetne inteligencije u otkrivanju i razvoju lijekova

master's thesis

• Title (english): Legal regulation of artificial intelligence in drug discovery and development
• Author: Doris Skaramuca
• Mentor: Sunčana Roksandić (mentor)
• Committee member: Sunčana Roksandić (predsjednik povjerenstva)
• Committee member: Maja Munivrana (član povjerenstva)
• Committee member: Aleksandar Maršavelski (član povjerenstva)
• Granter: University of Zagreb; Faculty of Law; (Criminal Law); Zagreb
• Defense date and country: 2023-09-11, Croatia
• Scientific / art field, discipline and subdiscipline: SOCIAL SCIENCES; Law

Abstract

Od samih početaka ljudi su koristili alate koji su nam pomogli u razvoju i preživljavanju. Danas smo razvili alate koji ne samo da olakšavaju naš svakodnevni život, već bi mogli biti bolji od nas u borbi protiv mnogih značajnih problema s kojima se suvremeni ljudi suočavaju.
Posebno je to vidljivo u polju medicine te razvoja lijekova, gdje se dosad neviđenom brzinom događaju pomaci na kakve se prije, bez pomoći tih novih alata, čekalo godinama.
U ovom radu objasnit ću kako je umjetna inteligencija revolucionirala proces pronalaska i razvoja lijekova, koje su koristi tih sustava, ali i koji su potencijalni rizici. Također ću raspravljati o regulaciji umjetne inteligencije, odnosno kako je ona regulirana trenutno, je li to dovoljno te kako bi trebalo regulirati njenu upotrebu u razvoju i proizvodnji lijekova.

Abstract (english)

From the very beginning, humans have used tools to help us develop and survive. Today, we have developed tools that not only make our daily lives easier, but could be better than us in the fight against many significant problems that modern people face.
This is especially visible in the field of medicine and the development of medicines, where advances are taking place at an unprecedented speed, for which, without the help of these new tools, we had to wait for years.
In this paper, I will explain how artificial intelligence revolutionized the process of discovery and development of medicines, what are the benefits of these systems, but also what are the potential risks. I will also discuss the regulation of artificial intelligence, that is, how it is currently regulated, whether it is enough, and how its use in the development and production of medicines should be regulated.

• Keywords: umjetna inteligencija; razvoj lijekova; otkrivanje lijekova; pravna regulacija; Zakon o umjetnoj inteligenciji; big pharma; rizik; prednosti AI; mane AI; ulaganje; AI istraživanje i razvoj
• Keywords (english): artificial intelligence; drug development; drug discovery; legal regulation; AI Act; big pharma; risk; AI advantages; AI faults; investment; AI research and development
• Language: croatian
• URN:NBN: urn:nbn:hr:199:388157
• Study programme: Title: Law; Study programme type: university; Study level: integrated undergraduate and graduate; Academic / professional title: magistar/magistra prava (magistar/magistra prava)
• Type of resource: Text
• File origin: Born digital
• Access conditions: Open access
• Created on: 2023-09-18 12:09:33